Latest total assets for EUCRU: $12M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) posts a total assets of $12M as of December 2022. That compares with $110M in the prior-year period — down 88.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War)'s total assets was $110M. The latest reading is $12M — a 88.1% year-over-year decrease (period ending December 2022). Use the history and growth charts on this page for a longer lookback.
Total Assets is one piece of Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War)'s financial statement story. At $12M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for EUCRU's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War)'s other metric pages and overview cover the third.